Author: Kim, Ah Young; Jung, Se Yong; Choi, Jae Young; Kim, Gi Beom; Kim, Young-Hwue; Shim, Woo Sup; Kang, I-Seok; Jung, Jo Won
Title: Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases Document date: 2016_9_28
ID: 0ipmswy4_6
Snippet: We also investigated the patients hospitalized for RSV infection despite receiving palivizumab; factors included their age and calendar month at RSV infection, and factors related to infection severity. For infection severity, we reviewed their visit to the emergency department and ICU admissions, hospital and ICU length of stay, oxygen requirements, mechanical ventilation use, and delay of elective operation. According to different types of hear.....
Document: We also investigated the patients hospitalized for RSV infection despite receiving palivizumab; factors included their age and calendar month at RSV infection, and factors related to infection severity. For infection severity, we reviewed their visit to the emergency department and ICU admissions, hospital and ICU length of stay, oxygen requirements, mechanical ventilation use, and delay of elective operation. According to different types of heart disease, the rate of RSV infection, all-cause and RSV related mortality, and doses of palivizumab were analyzed. RSV infection was confirmed by direct fluorescent antibody staining, culture, or reverse-transcriptase polymerase chain reaction on nasopharyngeal swabs or aspirates according to policy of each center. We noted the number of patients with breakthrough RSV infection and mortality, by comparison to doses of palivizumab prophylaxis according to type of CHD.
Search related documents:
Co phrase search for related documents- aspirate nasopharyngeal swab and stay ICU length hospital: 1
- chain reaction and stay ICU length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- chain reaction and stay ICU length hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- different type and stay ICU length: 1
- emergency department and stay ICU length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- emergency department and stay ICU length hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9
- heart disease and stay ICU length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- heart disease and stay ICU length hospital: 1, 2, 3, 4, 5, 6
- ICU emergency department admission and stay ICU length: 1
- ICU emergency department admission and stay ICU length hospital: 1
- ICU emergency department and stay ICU length: 1, 2, 3
- ICU emergency department and stay ICU length hospital: 1, 2, 3
- ICU length and stay ICU length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ICU length and stay ICU length hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- infection severity and stay ICU length: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- infection severity and stay ICU length hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9
- nasopharyngeal swab and stay ICU length: 1, 2, 3
- nasopharyngeal swab and stay ICU length hospital: 1, 2
- oxygen requirement and stay ICU length hospital: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date